Drugs / p53 peptide vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00019916 | Jun 2000 → Jul 2006 | breast cancer, ovarian cancer | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | p53 peptide vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00019916 ↗ |
| Modality | Vaccine | “p53 peptide vaccine” NCT00019916 ↗ |
| Route | Subcutaneous | “p53 peptide vaccine subcutaneously (SC)” NCT00019916 ↗ |